Search - tctmd.com

Displaying 1 - 20 of 594

Sort: Relevancy | Date

News Conference News ACC 2026

Sirolimus DCB in Peripheral Disease Makes Strides in Hard Outcomes: SirPAD

L.A. McKeown

April 02, 2026

News Industry News

SirPAD: Primary Results confirm the safety and efficacy of Sirolimus Coated Balloon in PAD

March 30, 2026

News Conference News ACC 2026

Impella Support in High-Risk PCI Doesn’t Help, Might Harm: CHIP-BCIS3

Yael L. Maxwell

March 29, 2026

News Conference News ACC 2026

What’s Going to Be Hot at ACC 2026

Michael O'Riordan

March 20, 2026

News Daily News

No Major Progress on Making CV Care More Affordable: JACC Stats

Todd Neale

March 18, 2026

News Daily News

Novel VECTOR Procedure Creates Percutaneous Aorto-Coronary Bypass

Yael L. Maxwell

January 14, 2026

News Daily News

JACC Debuts Data Digest on CV Health in the United States

Caitlin E. Cox

January 12, 2026

News Daily News

Year in Review: STORM-PE, CREST-2, and LIFE-BTK Headline Endovascular News

Todd Neale

December 26, 2025

News Daily News

Uterine Fibroids Increase Future Risk of ASCVD for Up to 10 Years

Caitlin E. Cox

December 10, 2025

News Conference News AHA 2025

Liberal Transfusion Doesn’t Decrease MACE in Surgery Patients at High Cardiac Risk: TOP

Caitlin E. Cox

November 10, 2025

News Conference News AHA 2025

Evolocumab Cuts MACE Risk in Patients Without Prior MI, Stroke: VESALIUS-CV

Michael O'Riordan

November 08, 2025

News Conference News TCT 2025

LIFE-BTK: 3-Year Data Keep Dissolving Scaffold’s Durability Hopes Alive in CLTI

L.A. McKeown

October 27, 2025

News Opinion CV Team Dispatch

October 2025 Dispatch for the CV Team

L.A. McKeown

October 25, 2025

News Daily News

ACC: It’s Time for Clinicians to Address Inflammation in CVD

Caitlin E. Cox

October 03, 2025

News Conference News ESC 2025

AQUATIC: More Than 6 Months After PCI, Don’t Use Aspirin With OAC

Todd Neale

September 01, 2025

News Industry News

Concept Medical Announces First Patient Enrollment in MAGICAL-SV IDE Trial, Expanding its Coronary Clinical Program Across the U.S. and Europe

August 01, 2025

News Daily News

POPCORN: Hemodialysis Patients Fare Well With Tailored PAD Therapies

L.A. McKeown

July 15, 2025

News Industry News

Fondazione Ricerca e Innovazione Cardiovascolare Completes Enrollment in TRANSFORM II RCT, A landmark study comparing MagicTouch SCB vs DES in Native Coronary Vessels

June 12, 2025

News Daily News

GLP-1s Reduce Limb and Cardiac Events in Peripheral Artery Disease

L.A. McKeown

June 12, 2025

News Conference News ACC 2025

SOUL: Oral Semaglutide Bests Usual Care in High-Risk Type 2 Diabetes

Michael O'Riordan

March 29, 2025

Advertisement

Sirolimus DCB in Peripheral Disease Makes Strides in Hard Outcomes: SirPAD

SirPAD: Primary Results confirm the safety and efficacy of Sirolimus Coated Balloon in PAD

Impella Support in High-Risk PCI Doesn’t Help, Might Harm: CHIP-BCIS3

What’s Going to Be Hot at ACC 2026

No Major Progress on Making CV Care More Affordable: JACC Stats

Novel VECTOR Procedure Creates Percutaneous Aorto-Coronary Bypass

JACC Debuts Data Digest on CV Health in the United States

Year in Review: STORM-PE, CREST-2, and LIFE-BTK Headline Endovascular News

Uterine Fibroids Increase Future Risk of ASCVD for Up to 10 Years

Liberal Transfusion Doesn’t Decrease MACE in Surgery Patients at High Cardiac Risk: TOP

Evolocumab Cuts MACE Risk in Patients Without Prior MI, Stroke: VESALIUS-CV

LIFE-BTK: 3-Year Data Keep Dissolving Scaffold’s Durability Hopes Alive in CLTI

October 2025 Dispatch for the CV Team

ACC: It’s Time for Clinicians to Address Inflammation in CVD

AQUATIC: More Than 6 Months After PCI, Don’t Use Aspirin With OAC

Concept Medical Announces First Patient Enrollment in MAGICAL-SV IDE Trial, Expanding its Coronary Clinical Program Across the U.S. and Europe

POPCORN: Hemodialysis Patients Fare Well With Tailored PAD Therapies

Fondazione Ricerca e Innovazione Cardiovascolare Completes Enrollment in TRANSFORM II RCT, A landmark study comparing MagicTouch SCB vs DES in Native Coronary Vessels

GLP-1s Reduce Limb and Cardiac Events in Peripheral Artery Disease

SOUL: Oral Semaglutide Bests Usual Care in High-Risk Type 2 Diabetes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content